123 related articles for article (PubMed ID: 31176754)
1. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains.
Carcas AJ; Sevillano D; González N; Alou L; Gómez-Gil R; Muñoz M; Llanos L; Sanchez-Villanueva RJ; Gonzalez-Parra E; Giménez MJ; Aguilar L
J Glob Antimicrob Resist; 2019 Dec; 19():241-251. PubMed ID: 31176754
[TBL] [Abstract][Full Text] [Related]
2. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
4. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
[TBL] [Abstract][Full Text] [Related]
5. Comparative Minimal Inhibitory and Mutant Prevention Concentration of Eight Antimicrobial Agents Against
Yang F; Chen P; Wang H; Xing X; Wang S; Ishaq HM; Liao W
Microb Drug Resist; 2022 Feb; 28(2):229-235. PubMed ID: 34851749
[No Abstract] [Full Text] [Related]
6. Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.
So W; Crandon JL; Hamada Y; Nicolau DP
J Antimicrob Chemother; 2016 Feb; 71(2):428-37. PubMed ID: 26559690
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
[TBL] [Abstract][Full Text] [Related]
8. Detection of Extended-Spectrum Beta-Lactamases (ESBLs) and Antibiotic Susceptibility Patterns in Klebsiella pneumoniae in Western, Iran.
Shakib P; Ramazanzadeh R; Taherikalani M; Nouri B
Infect Disord Drug Targets; 2018; 18(2):156-163. PubMed ID: 28707597
[TBL] [Abstract][Full Text] [Related]
9. Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
Speller DC; Bint AJ; Stephens M
J Antimicrob Chemother; 1977 Sep; 3(5):483-91. PubMed ID: 332682
[No Abstract] [Full Text] [Related]
10. Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.
Noel AR; Attwood M; Bowker KE; Kim A; Krause KM; MacGowan AP
Int J Antimicrob Agents; 2019 Nov; 54(5):626-632. PubMed ID: 31299297
[TBL] [Abstract][Full Text] [Related]
11. Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
Gaibani P; Colombo R; Arghittu M; Cariani L; Ambretti S; Bua G; Lombardo D; Landini MP; Torresani E; Sambri V
New Microbiol; 2014 Jan; 37(1):87-90. PubMed ID: 24531175
[TBL] [Abstract][Full Text] [Related]
12. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
13. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
[TBL] [Abstract][Full Text] [Related]
14. Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit.
Royle J; Halasz S; Eagles G; Gilbert G; Dalton D; Jelfs P; Isaacs D
Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F64-8. PubMed ID: 10325816
[TBL] [Abstract][Full Text] [Related]
15. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
Sutherland CA; Verastegui JE; Nicolau DP
Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):39. PubMed ID: 27316973
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Szabó D; Máthé A; Filetóth Z; Anderlik P; Rókusz L; Rozgonyi F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1287-91. PubMed ID: 11257049
[TBL] [Abstract][Full Text] [Related]
17. Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
Escolà-Vergé L; Larrosa N; Los-Arcos I; Viñado B; González-López JJ; Pigrau C; Almirante B; Len O
J Glob Antimicrob Resist; 2019 Dec; 19():28-31. PubMed ID: 30825700
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
19. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
[TBL] [Abstract][Full Text] [Related]
20. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.
Kesteman AS; Ferran AA; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2009 Nov; 53(11):4740-8. PubMed ID: 19738020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
